Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NATUS MEDICAL INCORPORATED

(NTUS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

GUIDANCE: (NTUS) NATUS MEDICAL INCORPORATED Expects Fiscal Year 2021 EPS Range $1.13 - $1.18

11/04/2021 | 03:11pm EST


ę MT Newswires 2021
All news about NATUS MEDICAL INCORPORATED
01/10Natus Medical Boosts Q4, Full-Year Revenue Outlook
MT
01/10NATUS MEDICAL INCORPORATED : Announces Preliminary 2021 Fourth Quarter and Full Year Reven..
PU
01/10Natus Announces Preliminary 2021 Fourth Quarter and Full Year Revenue
AQ
01/10Natus Medical Incorporated Provides Preliminary Revenue Guidance for the Fourth Quarter..
CI
01/07Natus to Participate in the 24th Annual Needham Virtual Growth Conference
AQ
01/03Natus Medical to Hold 2021 Fourth Quarter Financial Results Conference Call on February..
AQ
2021Natus Medical Names New CEO
MT
2021NATUS MEDICAL INCORPORATED : Announces Executive Transition - Form 8-K
PU
2021NATUS MEDICAL INC : Financial Statements and Exhibits (form 8-K)
AQ
2021Natus Medical Incorporated Announces Resignation of Jonathan A. Kennedy as President an..
CI
More news
Financials (USD)
Sales 2021 471 M - -
Net income 2021 23,8 M - -
Net Debt 2021 - - -
P/E ratio 2021 31,9x
Yield 2021 -
Capitalization 754 M 754 M -
Capi. / Sales 2021 1,60x
Capi. / Sales 2022 1,55x
Nbr of Employees 1 420
Free-Float -
Chart NATUS MEDICAL INCORPORATED
Duration : Period :
Natus Medical Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NATUS MEDICAL INCORPORATED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 22,33 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Thomas J. Sullivan President, Chief Executive Officer & Director
Benjamin Drew Davies Chief Financial Officer & Executive Vice President
Joshua H. Levine Non-Executive Chairman
D. Christopher Chung Chief Medical Officer & VP-Regulatory Affairs
Ivan Pandiyan Senior Director-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
NATUS MEDICAL INCORPORATED-2.36%783
THERMO FISHER SCIENTIFIC-14.91%221 810
DANAHER CORPORATION-18.92%190 628
INTUITIVE SURGICAL, INC.-26.40%94 475
SIEMENS HEALTHINEERS AG-11.61%73 622
EDWARDS LIFESCIENCES CORPORATION-16.15%67 821